Vancouver, British Columbia – TheNewswire – August 14, 2020 – Blackhawk Growth Corp. (CSE:BLR); (CNSX:BLR.CN); (Frankfurt:0JJ); (OTC:BLRZF) (the “Corporation” or “Blackhawk”), is pleased to announce that it has added a member to its strategic advisory board to consult with the Board of Directors and Senior Management of the Company. Blackhawk has appointed Dr. Krista Leicht as its newest member to the advisory board. Dr. Leicht’s involvement and medical expertise will be a valuable addition to the team and will greatly assist Blackhawk in realizing its vision and investment goals. Blackhawk will continue to bolster its board with medical and scientific advisors to advance its current and future planned initiatives.
Dr. Krista Leicht is a Canadian-trained and Alberta-licensed Medical Doctor and Psychiatrist, who brings over twenty years of Clinical experience to the team. She has divided her time in a busy practice, between inpatient and outpatient care, treating both the General Adult Psychiatry population, and specializing in addressing the complex needs of Developmentally Handicapped individuals. Dr. Leicht maintains a hospital practice at Alberta Hospital Edmonton and sees outpatients in a South Edmonton clinic. She continues to teach medical students, residents, and provides further education to Family Practice colleagues. Dr. Leicht’s goal in clinical practice and in her own life has always been to Go Beyond – to provide unique and innovative treatments that better enrich the lives of patients is her mission.
“I am looking forward to working with such a dynamic and innovative group” said Dr. Krista Leicht. “I’m confident that together, we will further develop and bring success to Blackhawk’s Medical initiatives. There is much potential for existing projects and our pending new expansions in this area.”
Frederick Pels, CEO of Blackhawk states: “We are pleased to welcome Dr. Leicht to our team. She brings a wealth of medial knowledge and experience that we will surely leverage as we look to expand and further develop our operations. Her support and guidance will be a relied upon source to further Blackhawk as a leader in the healthcare space. On behalf of our whole team, we look forward to working with Dr. Leicht and updating our shareholders with our progress over the coming weeks.”
For further information please contact:
Frederick Pels, Chief Executive Officer
Cautionary Note Regarding Forward-Looking Statement
All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.